DaVita Inc. (NYSE:DVA) Shares Sold by ExodusPoint Capital Management LP

ExodusPoint Capital Management LP lessened its stake in DaVita Inc. (NYSE:DVA) by 39.3% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 36,117 shares of the company’s stock after selling 23,399 shares during the quarter. ExodusPoint Capital Management LP’s holdings in DaVita were worth $5,401,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of DVA. Amundi boosted its holdings in shares of DaVita by 116.4% in the fourth quarter. Amundi now owns 446,386 shares of the company’s stock valued at $68,726,000 after acquiring an additional 240,126 shares in the last quarter. FMR LLC lifted its position in DaVita by 659.9% in the third quarter. FMR LLC now owns 177,406 shares of the company’s stock worth $29,082,000 after purchasing an additional 154,061 shares during the period. Skandinaviska Enskilda Banken AB publ boosted its stake in DaVita by 256.8% during the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 162,233 shares of the company’s stock valued at $24,301,000 after purchasing an additional 116,758 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of DaVita by 17.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 609,076 shares of the company’s stock valued at $99,846,000 after purchasing an additional 92,014 shares during the period. Finally, California Public Employees Retirement System raised its stake in shares of DaVita by 75.1% in the 4th quarter. California Public Employees Retirement System now owns 196,788 shares of the company’s stock worth $29,430,000 after buying an additional 84,375 shares in the last quarter. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Stock Performance

Shares of DVA opened at $149.37 on Friday. The company has a 50-day moving average of $155.75 and a two-hundred day moving average of $157.23. The stock has a market cap of $11.95 billion, a price-to-earnings ratio of 13.91, a PEG ratio of 1.07 and a beta of 1.04. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. DaVita Inc. has a one year low of $125.64 and a one year high of $179.60.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, equities research analysts expect that DaVita Inc. will post 10.76 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the company. StockNews.com cut DaVita from a “buy” rating to a “hold” rating in a research note on Wednesday. Barclays raised their price objective on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a report on Friday, February 21st. Finally, Cowen restated a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. One analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $166.33.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.